ClinConnect ClinConnect Logo
Search / Trial NCT06211491

Autonomic Dysreflexia in Spinal Cord Injuries: UDS Filling Speed Impact

Launched by PUSAN NATIONAL UNIVERSITY YANGSAN HOSPITAL · Jan 8, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a condition called Autonomic Dysreflexia (AD), which can occur in people with spinal cord injuries. The researchers want to learn how the speed at which the bladder fills with liquid affects the occurrence and characteristics of AD. They will look at patients who have had a spinal cord injury for at least six months and who have experienced AD due to a full bladder in previous tests. The goal is to find out whether the way the bladder expands or the rate of filling has a bigger effect on AD symptoms.

To be eligible for this trial, participants must have a specific type of spinal cord injury at a certain level (between C1 and T6) and be classified as AIS A or B, which relates to the severity of their injury. However, people with very high blood pressure during testing, those who are unstable due to other health issues, or those with a urinary tract infection cannot participate. If someone is eligible and chooses to join, they will undergo tests to help the researchers gather important information about AD and bladder function.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients with chronic spinal cord injury 6 months after receiving the award
  • 2. Patients with confirmed AD due to bladder fullness in previous urodynamic test
  • 3. Patients confirmed to have neurological damage level C1-T6, AIS A or B
  • Exclusion Criteria:
  • 1. Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test
  • 2. Patients who cannot undergo testing due to hemodynamic instability
  • 3. Patients who cannot undergo testing due to overt urinary tract infection

About Pusan National University Yangsan Hospital

Pusan National University Yangsan Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to investigate new therapies, improve treatment protocols, and enhance patient outcomes. With a commitment to ethical standards and rigorous scientific methodology, Pusan National University Yangsan Hospital collaborates with multidisciplinary teams to ensure the highest quality of clinical research, contributing significantly to the global medical community and fostering advancements in healthcare.

Locations

Yangsan, Gyeongnam, Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Sungchul Huh, Ph.D

Principal Investigator

Pusan National University Yangsan Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported